Celon Pharma SA's total assets for Q3 2024 were zł619.15M, an increase of 7.43% from the previous quarter. DE:8RP total liabilities were zł102.91M for the fiscal quarter, a -12.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.